¸¤¼ïÊÌ°äÅÁÀ¼À´µ(07ǯÅÙÅÐϿƬ¿ô½ç) | 1°Ì¥À¥Ã¥¯¥¹¥Õ¥ó¥È | 2°Ì¥Á¥ï¥ï | 3°Ì¥×¡¼¥É¥ë | 4°Ì¥è¡¼¥¯¥·¥ã¡¼¥Æ¥ê¥¢ | 5°Ì¥Ý¥á¥é¥Ë¥¢¥ó |
---|
38
|
60 | 114 | 83 | 6 | 35 | 22 | 30 | 58 | 85 | 79 | 23 | 35 | 15 | 24 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
·Á¼Á | ·ì´É¡¦·ì±Õ | Ǿ¿À·Ð | ¶Ú¹ü³Ê¡¦·ë¹çÁÈ¿¥ | ¸ÆµÛ´ï | ½Û´Ä´ï | ¾Ã²½´ï | ¿ÕǢϩ | ÀèÅ·´ñ·Á | ÆâʬÈ硦Âå¼Õ | ´ã¡¦¼ª¡¦É¡ | ¼ðáç | ÈéÉæ | ¥¢¥ì¥ë¥®¡¼¡¦Ì鱅 | ¤½¤Î¾ |
ÆâʬÈ硦Âå¼Õ¡¡¡¡¡¡¡¡¡¡85 |
---|
ÄÌÈÖ | ¼À ´µ ̾ | ¼ç ¤Ê ¾É ¾õ | È÷¡¡¡¡¡¡¡¡¡¡¹Í | °äÅÁ·ÁÂÖ | ¼ç¤Ê³ºÅö¸¤¼ï |
---|---|---|---|---|---|
10 |
Acromegaly ¥¢¥¯¥í¥á¥¬¥ê¡¼ ËöüÈîÂç¾É |
´éÌ̤Υѡ¼¥Ä¤äÂÀè¤Ê¤É¤¬½ù¡¹¤ËÈîÂç¡¢²¼¿âÂÎ¥Û¥ë¥â¥ó°Û¾ïʬÈ礬¼ç°ø¡£ | À®Ä¹¥Û¥ë¥â¥ó¤Î²á¾ê»ºÀ¸¤Ëµ¯°ø¤¹¤ëÆÃÄê¤ÎÂΤÎÁÈ¿¥¤Î²á¾ê¤ÊÀ®Ä¹¡£¹â»é·ì¾É¤ä´Î¾ã³²¡¦ÅüǢɡ¦Ç¢Êø¾É¤Î¿´ÇÛ¡£È¯¾ðµÙ»ß´ü¤Î´Ö¤Î»èüµðÂç¾É¡¢Â¿°û¿Ǣ¡£(*¥¢¥ë¥®¥Ë¥ó¡¦¥Ð¥½¥×¥ì¥·¥ó(AVP)¥ì¥Ù¥ë¤ÎÉÔ½½Ê¬¤Ê¾å¾º*) | ¾ïÀ÷¿§ÂÎÀ¡¢unknown | ¥Ó¡¼¥°¥ë¡¢G¥·¥§¥Ñ¡¢Ç |
11 |
ACTH-independent adrenal Cushing syndrome, somatic ACTH Èó°Í¸Éû¿Õ¥¯¥Ã¥·¥ó¥°¾É¸õ·² |
¿©ÍßÁý¡Ê¿¿©¡Ë¡¢Â¿°û¡¦Â¿Ç¢¡¢Á´¿ÈÀ¤Îº¸±¦ÂоÎæÌÓ¡¢Çö¤¯¥·¥ï¤¬´ó¤ëÈéÉ桢ʢÉô¤¬ËĤì¤ë¥Ó¥äîÂη¿ | Éû¿Õ¤¬¸¶°ø¤Ç¥³¥ë¥Á¥¾¡¼¥ë¤ò²á¾ê¤ËʬÈ礹¤ë¾õÂÖ¡£¤Á¤Ê¤ß¤Ë¾¤Ï¡¢²¼¿âÂΤ«¤éÉû¿ÕÈé¼Á»É·ã¥Û¥ë¥â¥óACTH¤¬²á¾ê¤ËʬÈ礵¤ì¤½¤Î·ë²Ì¥³¥ë¥Á¥¾¡¼¥ë¤¬Áý¤¨¤ë¾õÂÖ¤òACTH°Í¸À¥¯¥Ã¥·¥ó¥°¾É¸õ·²¡¢²¼¿âÂΰʳ°¤«¤éACTH¤¬²á¾ê¤ËʬÈ礵¤ì¤ëɵ¤¤ò°Û½êÀACTH¾É¸õ·²¡¢ | unknown | ¿ |
12 |
Adrenal cortical atrophy Éû¿ÕÈé¼Á°à½Ì¾É |
ºÇ½ªÅª¤Ë¤Ï°×´¶À÷À | Éû¿ÕÈé¼Á¥Û¥ë¥â¥ó¤¬ºî¤é¤ì¤Ê¤¤¤Ê¤É¤Ê¤ó¤é¤«¤ÎÍýͳ¤Ë¤è¤êÉû¿ÕÈé¼Á¤Î»Å»ö¤¬¤Ê¤¯¤Ê¤ë¤³¤È¤Ç°à½Ì¤·¤Æ¤¤¤¯¡£Éû¿Õ¤Ï¾®¤µ¤Ê´ï´±¤Ê¤Î¤Ç°à½Ì¤·¤Æ¤¤¤ë¤«¤É¤¦¤«¤òÃΤë¤Î¤Ï¥Ò¥È¤Ç¤âÆñ¤·¤¤ | unknown | ¿ |
17 |
Alloxan-diabetes ¥¢¥í¥¥µ¥óÅüÇ¢ |
* | ¥¤¥ó¥¹¥ê¥ó°Í¸·¿ÅüǢɤǵõ·ìÀ´§Æ°Ì®¼À´µ¤Î¸¶°ø¤È¤Ê¤ë | * | * |
21 |
Alpha-1-antitrypsin deficiency ¥¢¥ë¥Õ¥¡1¥¢¥ó¥Á¥È¥ê¥×¥·¥ó·ç»¾É |
´Î¾ã³²¡¢¸ÆµÛº¤Æñ¡¢ÓÒÅÇ¡¦²¼Î¡¡¦Ê¢¿å¡¦²«áÕ¡¦½Ð·ì·¹¸þ | ´Î¹ÅÊѤäÌçÌ®°µÐ¶¿Ê¾É¤Ç¿¤¯¤ÏÀ®Ä¹´ü¤Ç»àË´¡£¥¿¥ó¥Ñ¥¯¼Á¤òʬ²ò¤¹¤ë¹ÚÁÇ¡Ê¥×¥í¥Æ¥¢¡¼¥¼¡Ë¤ÎºîÍѤòÍÞÀ©¤¹¤ë¥¢¥ë¥Õ¥¡1¡¾¥¢¥ó¥Á¥È¥ê¥×¥·¥ó¤Î·ç»¡£ÆäËÇÙ¤ä´Î¡¤ÎÁÈ¿¥¤Ë¾ã³²¤¬À¸¤¸¡¢´Î¡¤¬¤³¤Î¹ÚÁǤòºÙ˦¤Î³°¤ËʬÈç¤Ç¤¤Ê¤¯¤Ê¤ê¹ÚÁǤ¬´ÎºÙ˦Æâ¤Ë¤¿¤Þ¤ê¡¢´ÎºÙ˦¤Î»½ý¤ò°ú¤µ¯¤³¤¹¡£ | ¾ïÀ÷¿§ÂÎÀ¡¢unknown | A¥³¥Ã¥«¡¼ |
24 |
Amyloidosis ¥¢¥ß¥í¥¤¥É¾É¡¢¥¢¥ß¥í¥¤¥É¡¼¥·¥¹ |
¡´ï¤Ë¤è¤Ã¤Æ¾É¾õ¤ÏÍÍ¡¹¤À¤¬¿Õ¡¤Î¾ì¹ç¤Ï¥Í¥Õ¥í¡¼¥¼¤ä¿ÕÉÔÁ´¡¢¿´Â¡¤Î¾ì¹ç¤ÏÉÔÀ°Ì®¤ä¿´ÉÔÁ´¡¢¿À·Ð¾É¾õ¤È¤·¤Æ¤Ï¼º¿À¡¢ÌëÇ¢¡¢´¶³Ð¤¬Æߤ¯¤Ê¤ë¡¢°ßIJ¾ã³²¡¢Ëö¾¿¿À·Ð¤ä¼«Î§¿À·Ð¤Î¾ã³²(¼ê¤Τ·¤Ó¤ì¡¢Ëãáã¡¢ÇÓÇ¢¤Î°Û¾ï¡¢ÊØÈë¡¢²¼Î¡)¡¢±¿Æ°¾ã³² | Âå¼ÕÀ´Î¼À´µ¡£¥¢¥ß¥í¥¤¥É¤È¤¤¤¦°Û¾ï¥¿¥ó¥Ñ¥¯¤¬Â¡´ï¤ËÄÀÃ夷¡¢¤½¤Î¡´ï¤¬Àµ¾ï¤Ëµ¡Ç½¤·¤Ê¤¯¤Ê¤ëɵ¤¤ÎÁí¾Î¡£Á´¿ÈÀ¤È¸Â¶ÉÀ(¸Â¶ÉÀ¤Ë¥¢¥ë¥Ä¥Ï¥¤¥Þ¡¼É¤ä¥×¥ê¥ª¥ó¤Ê¤É)¡£Ìȱ֥°¥í¥°¥ê¥óÃÁÇò¤È¤Ï°Û¤Ê¤ëÆüì¤ÊNËöü¥¢¥ß¥Î»ÀÇÛÎó¤ò¤â¤Ä¥¢¥ß¥í¥¤¥É¡£¼çÍפʥ¢¥ß¥í¥¤¥É¾É¤Ë¤Ï3¥¿¥¤¥×¤¢¤ë¡£Ëö¾¿À´¶³Ð¤ª¤è¤Ó±¿Æ°¿À·Ð¾ã³²¡¢¼«Î§¿À·Ð¾ã³²¡¢¿´·ì´É·Ï¤ª¤è¤Ó¿Õ¥¢¥ß¥í¥¤¥É¡£¼êº¬´É¾É¸õ·²¤È¾Ë»ÒÂΰ۾ï¤âµ¯¤³¤ê¤¦¤ë | ¾ïÀ÷¿§ÂÎÀ¡¢unknown | ½©Åĸ¤¡¢¥Ó¡¼¥°¥ë¡¢C¥·¥ã¡¼¥Ú¥¤¡¢Ç¡¢·Ü |
25 |
Amyloidosis, AA Æó¼¡À¥¢¥ß¥í¥¤¥É¾É¡¢¥¢¥ß¥í¥¤¥É¡¼¥·¥¹ |
Ʊ¾å | ËýÀ·Ð²á¤ò¤È¤ë²½Ç¿À¼À´µ¡¢ËýÀ´¶À÷¾É¡¢ÁÈ¿¥Ç˲õÀ¼À´µ¤Ë¸¶°ø¡£¥¢¥ß¥í¥¤¥É¤¬¤Ä¤¯¤é¤ì¤ë¸¶°ø¤Ï¤Ï¤Ã¤¤ê¤·¤Æ¤¤¤Ê¤¤¤¬¤Ê¤ó¤é¤«¤ÎÌȱÖÈ¿±þ¤È´Ø¤ï¤ê¤¬¤¢¤ë¤È¤µ¤ì¤Æ¤¤¤ë¡£Æ°Êª¤Ç¤Ï¸¶È¯À¥¢¥ß¥í¥¤¥É¡¼¥·¥¹¤Ïµ©¤Ç¤Û¤È¤ó¤É¤¬Æó¼¡À¡£(Æó¼¡À¡á³ȯÀ¡£ÂеÁ¸ì¤Ï¸¶È¯À(ºÇ½é¤Î¡¢Âè°ì¤Î)) | ¾ïÀ÷¿§ÂÎÀ¡¢unknown | C¥·¥ã¡¼¥Ú¥¤ |
26 |
Amyloidosis, renal ¿ÕÀ¥¢¥ß¥í¥¤¥É¾É¡¢¥¢¥ß¥í¥¤¥É¡¼¥·¥¹ |
̵µ¤ÎÏ¡¢ÂνŸº¾¯¡¢Â¿°û¿Ǣ¡¢»åµåÂΤäÇ¢ºÙ´ÉÉÕ¶á¤Ë¥¢¥ß¥í¥¤¥É¤¬ÄÀÃ夹¤ë¤³¤È¤Ë¤è¤ë¥Í¥Õ¥í¡¼¥¼¡¢¿ÕÉÔÁ´ | Ä̾ï5ºÐ°Ê¾å¤Çȯ¾É¡¢»õ·Ô¤¬´¥Á礷¤¿¾ì¹çÄãÂβ¹¡¦ÓÒÅÇ¡¦²¼Î¡¡¦¸ý¤ÎÄÙáç¤â¸«¤é¤ì¤ë | unknown ¾ïÀ÷¿§ÂÎÀ¡¢ | C¥·¥ã¡¼¥Ú¥¤¡¢Ç¡¢µí |
61 |
Bardet-Biedl syndrome 4 ¥Ð¥ë¥Ç¡¼¡¦¥Ó¡¼¥É¥ë¾É¸õ·² |
Gene: BBS4 ÈîËþ¡¢ÌÖË쿧ÁÇÊÑÀ¾É¡¢ËýÀ¿Õ¾ã³²¡¢ÀÁ£µ¡Ç½Äã²¼¾É¡Ê̵ȯ¾ð¡Ë¡¢Â¿»Ø¾É¡¦¹ç»Ø¾É |
¥Ò¥È¤Ç¤ÏÃÎǽ¾ã³²¤òȼ¤¦AR¤¬ÃΤé¤ì¤Æ¤¤¤ë¡ÊÆñÉÂÂоݡˢªAR³ÎÄê07/17 | AR | ¥×¡¼¥ê¡¼ |
158 |
Cushing disease ¥¯¥Ã¥·¥ó¥°É |
½é´ü¤Ï¿©Íߤä°û¿åÎ̤äÇ¢Î̤ÎÁý²Ã¡¢Ê¢ÉôËÄËþ¡¢º¸±¦ÂоݤÇáڤߤΤʤ¤Ã¦ÌÓ¡¢³°½ýÀפÎÈé²¼½Ð·ì¡¢¤Ë¤¤ÓÍͤΤǤ¤â¤Î¡¢ÈéÉæ¤Î¹õ¤º¤ß¤Ê¤É | #¥¯¥Ã¥·¥ó¥°¾É¸õ·² ²¼¿âÂμðáç¤Ë¤è¤ëÉû¿ÕÈé¼Á»É·ã¥Û¥ë¥â¥óACTH¤ÎʬÈç²á¾ê¤¬Æó¼¡Åª¤ËÉû¿ÕÈé¼Á¤òÈîÂ礵¤»Åü¼Á¥³¥ë¥Á¥³¥¤¥É¤¬²á¾êʬÈ礵¤ì¤ë¡£²¼¿âÂΤ¬¸¶È¯¤Ê¤Î¤ÇÉû¿ÕÈé¼Á¤Ë°ì»þŪ¤ÊÉÂÊѤÏ̵¤¤¡£¥¯¥Ã¥·¥ó¥°¾É¸õ·²¤È¤Î¾É¾õ¤Îº¹¤Ï¤Ê¤¤ | unknown | ¿ |
167 |
Deficiency of cytosolic arylamine N-acetylation ¥¢¥ê¡¼¥ë¥¢¥ß¥ó¤ÈN -¥¢¥»¥Á¥ë¥È¥é¥ó¥¹¥Õ¥§¥é¡¼¥¼¤Î·ç˳ |
¢¨Éµ¤¤Ç¤Ï¤Ê¤¤ |
Genes: NAT1, NAT2 ¤¹¤Ù¤Æ¤Î¸¤¤Ï¾åµ°äÅÁ»Ò¤ò»ý¤¿¤º¡¢¤½¤·¤Æ¤½¤Î°äÅÁ»Ò¤Ï¾ïÀ÷¿§ÂÎÎôÀ°äÅÁ¤¹¤ë¤È¤¤¤¦¸¦µæ |
AR | Á´ |
177 |
Diabetes ÅüǢɠ|
¿°û¿Ǣ¡¢¿©ÍßÁý²½(½é´ü)¤¹¤ë¤¬Á餻¤Æ¤¯¤ë¡¢¸µµ¤¾ÃÄÀ¡¢·ìÅüÃͤξ徺 | ÅüÂå¼Õ¤Î°Û¾ï¤Ë¤è¤Ã¤Æµ¯¤³¤ë¤È¤µ¤ì¡¢·ìÅüÃÍ(·ì±ÕÃæ¤Î¥Ö¥É¥¦ÅüÇ»ÅÙ)¤¬ÉÂŪ¤Ë¹â¤Þ¤ë¤³¤È¤Ë¤è¤Ã¤ÆÍÍ¡¹¤ÊÆÃħŪ¤Ê¹çÊ»¾É¤ò¤¤¿¤¹ | unknown | * |
179 |
Diabetes mellitus ¿¿ÀÅüǢɠ|
¿°û¿Ǣ¡¢¿©ÍßÁý²½(½é´ü)¤¹¤ë¤¬Á餻¤Æ¤¯¤ë¡¢¸µµ¤¾ÃÄÀ¡¢·ìÅüÃͤξ徺 | ¥¤¥ó¥¹¥ê¥óʬÈ礢¤ë¤¤¤ÏºîÍѤÎÉÔ¤ˤè¤ë»ý³Ū¹â·ìÅü¡£¥±¥È¥óÃßÀѤˤè¤êÓÒÅÇ¡¦Ã¦¿å | unknown | * |
183 |
Dwarfism ¾®¿Í¾É¡¢Äã¿ÈĹ¾É |
¶Ëü¤Ê¾®¤Ö¤ê | ¾É¾õ¤Î¤Ò¤È¤Ä¤È¤·¤ÆÄã¿ÈŤò¤¤¿¤¹ÍÍ¡¹¤Ê¼À´µ¤ò¾®¿Í¾É¤È¸Æ¾Î | unknown | * |
185 |
Dwarfism, hypochondroplastic Æð¹üÄã·ÁÀ®¾É¤Ë¤è¤ë¾®¿Í¾É |
ÀèÅ·À¤Î»Í»èû½Ì·¿Äã¿ÈĹ¾É | ÊÌ̾¥¢¥¤¥ê¥Ã¥·¥å¥»¥Ã¥¿¡¼¾®¿Í¾É¡£½ÐÀ¸»þ¡ÁÎ¥Æý»þ¤Þ¤Ç¤Îɽ¸½·¿¤ÏÀµ¾ï¤ÇÀ¸¸å2¥ö·îȾ¡Á4¥ö·î¤Þ¤Ç¤ËÇعü¤È»Í»è¤ÎÀ®Ä¹¤¬Ãø¤·¤¯ÃÙ¤ì¤À¤¹¡£1998ǯ¥Î¥ë¥¦¥§¡¼¤Ç¥Æ¥¹¥È¸òÇÛ¤¬¤Ê¤µ¤ì°äÅÁŪ¡¢Î×¾²Åª¡¢·ÁÂַ׬¡¢XÀþ»£±Æ¡¢¹üÁÈ¿¥¤È·ìÞù¤È¾®¿Í¾É¤ÎÇ¢Ãæ¤ÎÀ¸²½³ØŪÆÃħ¤òÄ´¤Ù¤é¤ì¤¿ | AR | I¥»¥Ã¥¿¡¼ |
186 |
Dwarfism, pituitary ²¼¿âÂÎÀÄã¿ÈĹ¾É¡¢²¼¿âÂÎÀ¾®¿Í¾É |
Á´¿ÈÀȯ°éÉÔÁ´ |
Genes:LHX3 ¿¤¯¤¬À¸¸å6½µ´Ö¤¯¤é¤¤¤«¤éÀ®Ä¹Ãٱ䡢ÂΤÎäÂÀ¤â¤â¤äÈø¤ÎæÌÓ¡¦ÌµÌÓ¡¢Çö¤¤ÈéÉ桦¤¦¤í¤³¾õ¡¢¤æ¤Ã¤¯¤ê¿Ê¤à²áÅ٤ο§ÁÇÄÀÃå¡¢Ä̾ïû̿ °äÅÁ»Ò¸¡ºº¥¢¥ê¡¡¥ª¥é¥ó¥À¥æ¥È¥ì¥Ò¥ÈÂç³Ø¤ÇG¥·¥§¥Ñ¤È¥Á¥§¥³¥¹¥ë¥Ð¥¥¢¥ó¥¦¥ë¥Õ¥É¥Ã¥° |
AR | G¥·¥§¥Ñ |
200 |
Ehlers-Danlos syndrome ¥¨¡¼¥é¥¹¡¦¥À¥ó¥í¥¹¾É¸õ·² |
ÈéÉæ¤Î²á¿Å¸¡¢ÀȼåÀ¡¢·ì¼ð¤¬Ç§¤á¤é¤ì¡¢´Ö»¤Éô¤ÎÁýÂç¤Ë¤è¤êÁßáÚ¤ò¼¨¤¹(Wiki) | ¥³¥é¡¼¥²¥óÀþ°Ý·ÁÀ®µ¡¹½¤Î°Û¾ï¤ò¸¶°ø¤È¤¹¤ë¾É¸õ·²¡£ÈéÉæ̵ÎϾɡ¢ÈéÉæÀȼå¾É¡¢²á¾êÃÆÎÏÀÈéÉæ¤È¤â¸Æ¤Ð¤ì¤ë(Wiki) | AD | * |
236 |
Fucosidosis, alpha ¦Á-¥Õ¥³¥·¥É¡¼¥·¥¹ |
Àº¿À±¿Æ°È¯Ã£ÃÙÂÚ¡¢¾®¤Ö¤ê¡¢°×´¶À÷À¡¢Â¿È¯À¹ü·ÁÀ®ÉÔÁ´¡¢Èï³Ñ·ì´É¼ð¡¢´ØÀá¹´½Ì¡¢¤±¤¤¤ì¤óȯºî¡¢´Î磼ð¡¢ÆñÄ°¡¢¥Ø¥ë¥Ë¥¢¡¢»ëÎϾ㳲 |
Genes:FUCA1 ¦Á-L-¥Õ¥³¥·¥À¡¼¥¼·ç»¤Ë¤è¤ëºÙ˦¥é¥¤¥½¥¾¡¼¥àÆâ¤Ø¤Î¥ª¥ê¥´ÅüÃßÀÑ¡£¥Ò¥È¤Î¾ì¹ç¤Ï2·¿¤Ëʬ¤±¤é¤ì¤ë¤³¤È¤¬Â¿¤¯¿Ê¹Ô¤ÎÁᤤ½Å¾É·¿¤ÈÈï³Ñ·ì´É¼ð¤òȼ¤¦¿Ê¹Ô¤Î´Ë¤ä¤«¤Ê·Ú¾É·¿¤¬ÃΤé¤ì¤ë¡£Èï³Ñ·ì´É¼ð¤È¤ÏɽÌ̤˲á¾ê¤Ê³Ñ²½¤òȼ¤¦·ì´É¼ð¡ÊµÖ¿¾¡Ë¤Î°ì¼ï¤Ç¾¯¤··ì¤Îº®¤¸¤Ã¤¿¤«¤µ¤Ö¤¿¤Î¤è¤¦¤Ë¤·¤«¸«¤¨¤Ê¤¤¤â¤Î¤â¤¢¤ë¡Ê°ìÈÌ»ô¤¤¼ç¤Ç¤¢¤ì¤ÐÌ¿¤¬´í¤¦¤¤Éµ¤¤Ë´Ø·¸À¤¬¤¢¤ë¤ÈÁÛÁü¤·¤Ë¤¯¤¤¡Ë |
AR | * |
238 |
Galactosialidosis ¥¬¥é¥¯¥È¡¦¥·¥¢¥ê¥É¡¼¥·¥¹ |
¹ü¤ÎÊÑ·Á¡¢´Î¡¤äç£Â¡¤Î¼ðÂç¡¢Áͷ¥إë¥Ë¥¢¡¢çÁ¥Ø¥ë¥Ë¥¢¡¢¿´ÉÔÁ´¡¢¿ÕÉÔÁ´¡¢¸ÆµÛ¾ã³²¤äÃæ¿õ¿À·Ð¾ã³²(¥ß¥ª¥¯¥í¡¼¥Ì¥¹¡¢¤±¤¤¤ì¤óȯºî) | ¥é¥¤¥½¥¾¡¼¥àÀÊݸîÃÁÇò¼Á/¥«¥Æ¥×¥·¥óA¡ÊPPCA¡Ë¤Î³èÀÄã²¼¤Ë¤è¤êÈó´Ô¸µËöü¤Ë¥·¥¢¥ë»À»Ä´ð¤ò»ý¤Ä¥ª¥ê¥´Åü¤äÅüÃÁÇò¼Á¤ª¤è¤ÓÅü»é¼Á¤¬Ê¬²ò¤µ¤ì¤º¤ËºÙ˦Æâ¤ËÃßÀѤ·¤ÆºÙ˦¤¬¾ã³²¤ò¼õ¤±¤ë¡£¥¬¥ó¥°¥ê¥ª¥·¥É¡¼¥·¥¹¤È¾É¾õ¤¬»÷¤ë¤¬¤³¤Á¤é¤Ï¤ä¤ä·Ú¤¤ | unknown | * |
240 |
Gangliosidosis ¥¬¥ó¥°¥ê¥ª¥·¥É¡¼¥·¥¹ |
¼ãÎð´ü¤Î±¿Æ°¼ºÄ´¤«¤é»Ï¤Þ¤ê¡¢¤±¤¤¤ì¤óȯºî¡¢»ëÎÏÄã²¼(¼ºÌÀ)¡¢ÃÔÊòÍ;ɾõ¤Ê¤É¤òµ¯¤³¤·Áá´ü»àË´ | ¥¬¥ó¥°¥ê¥ª¥·¥É¤Î¥é¥¤¥½¥¾¡¼¥àÃßÀÑÉ¡£»é¼ÁÂå¼Õ²óÏ©Ãæ¤ÎÆÃÄê¤Î¹ÚÁǤη绤ǻé¼Á¤Î°ì¼ï¤Ç¤¢¤ë¥¬¥ó¥°¥ê¥ª¥·¥É¤¬¿À·ÐºÙ˦¤Ê¤É¤Ë°Û¾ï¤ËÃßÀѤ¹¤ë¤³¤È¤Çµ¯¤³¤ë¡£ | unknown | * |
241 |
Gangliosidosis, GM1 GM1¥¬¥ó¥°¥ê¥ª¥·¥É¡¼¥·¥¹ |
Ê¢¿å¤ä»Í»è¤ÎÉâ¼ð¡¢¹üÊÑ·Á¡¢¤½¤Î¾¥¬¥ó¥°¥ê¥ª¥·¥É¡¼¥·¥¹»²¾È |
Genes:GLB1 GM1¥¬¥ó¥°¥ê¥ª¥·¥É¦Â¥¬¥é¥¯¥È¥·¥À¡¼¥¼·ç»¾É¡¢¥é¥¤¥½¥¾¡¼¥àÃßÀÑÉ |
AR | * |
242 |
Gangliosidosis, GM2, generic GM2¥¬¥ó¥°¥ê¥ª¥·¥É¡¼¥·¥¹ |
¥¬¥ó¥°¥ê¥ª¥·¥É¡¼¥·¥¹»²¾È | ¦Â¥Ø¥¥½¥µ¥ß¥Ë¥À¡¼¥¼·ç»¾É¡¢¥é¥¤¥½¥¾¡¼¥àÃßÀÑÉ | AR | * |
243 |
Gangliosidosis, GM2, GM2A deficiency GM2¥¬¥ó¥°¥ê¥ª¥·¥É¡¼¥·¥¹GM2A·ç»¾É |
¥¬¥ó¥°¥ê¥ª¥·¥É¡¼¥·¥¹»²¾È | ¥é¥¤¥½¥¾¡¼¥àÃßÀÑÉ | AR | * |
244 |
Gangliosidosis, GM2, type I(B variant) ¥¬¥ó¥°¥ê¥ª¥·¥É¡¼¥·¥¹GM2µ·¿ |
¥¬¥ó¥°¥ê¥ª¥·¥É¡¼¥·¥¹»²¾È |
Gene: HEXA ¥Æ¥¤¡Ý¥µ¥Ã¥¯¥¹¡ÊTay-Sachs¡ËÉ ¥é¥¤¥½¥¾¡¼¥àÃßÀÑÉ¡£¥Ø¥¥½¥µ¥ß¥Ë¥À¡¼¥¼¹ÚÁǤηçÇ¡¤Ëµ¯°ø¤¹¤ëÍÍ¡¹¤ÊÁÈ¿¥¤Ë¤ª¤±¤ëGM2¥¬¥ó¥°¥ê¥ª¥·¥É¡ÊÅü»é¼Á¤Î°ì¼ï¡Ë¤ÎÃßÀÑ |
AR | ྠ|
245 |
Gangliosidosis, GM2, type II(Sandhoff or variant 0) ¥¬¥ó¥°¥ê¥ª¥·¥É¡¼¥·¥¹GM2¶·¿ |
¿Ê¹ÔÀ¤Î¿À·Ð¶Úµ¡Ç½¾ã³²¡¦À®Ä¹¾ã³² |
Gene: HEXB ¥é¥¤¥½¥¾¡¼¥àÃßÀÑÉ¡£¥Ø¥¥½¥µ¥ß¥Ë¥À¡¼¥¼¹ÚÁǤηçÇ¡¤Ëµ¯°ø¤¹¤ëÍÍ¡¹¤ÊÁÈ¿¥¤Ë¤ª¤±¤ëGM2¥¬¥ó¥°¥ê¥ª¥·¥É¡ÊÅü»é¼Á¤Î°ì¼ï¡Ë¤ÎÃßÀÑ¡£ |
AR | ¥È¥¤¥×¡¼¡¢¥´¥ë¡¢Ç |
248 |
Gaucher disease, type I ¥¿¥¤¥×1¥´¡¼¥·¥§É |
¼Ð»ë¡¢À®Ä¹Ãٱ䡢¤±¤¤¤ì¤óȯºî¡¢°×¹üÀÞÀ¡¢´Î磼𡢷쾮ÈĤθº¾¯¡¢ÉÏ·ì | ¥°¥ë¥³¥»¥ì¥Ö¥í¥·¥¿¡¼¥¼Äã³èÀ¤Ë¤è¤ë¥é¥¤¥½¥¾¡¼¥à¼À´µ¡£¥Ò¥È¤Ç¤Ï3·¿¤Ëʬ¤±¤é¤ì¤ë¾ïÀ÷¿§ÂÎÀøÀ°äÅÁ | ñ°ì°äÅÁ»Ò | * |
262 |
Glycogen storage disease I Åü¸¶Éµ·¿ |
¾®¿©¡¢Äã·ìÅüȯºî(·îÎ𤬿ʤà¤È´ËϤµ¤ì¤ë)¡¢À®Ä¹Ãٱ䡢(É¡¤Ê¤É)½Ð·ì¡¢´Î¼ðÂç(Ê¢ÉôËÄËþ)¡¢¹â»é·ì¾É¡¢¹âÇ¢»À·ì¾É |
Gene: G6PC ¥Õ¥©¥ó¥®¡¼¥ë¥±¡£glucose-6-phosphatase°Û¾ï¤Ë¤è¤ë´Î¿Õ·¿¥°¥ê¥³¡¼¥²¥óÃßÀѾɡ£Â¿Î̤Υ°¥ê¥³¡¼¥²¥ó¤¬´Î¡¡¦¿Õ¡¤ËÃßÀÑ¡£ |
AR | * |
263 |
Glycogen storage disease ¶ Åü¸¶É¶·¿ |
½é´ü¤ÏÉÔ̲¤È±¿Æ°»þ¤Î¸ÆµÛº¤Æñ¤ò´Þ¤à¶ÚÎÏÄã²¼¡¢´Î¡¦¿´¼ðÂç¡¢¿´ÉÔÁ´¤ÇÁá´ü»àË´ | ¥Ý¥ó¥ÚÉÂ(¥Ý¥ó¥Ú¤Ïȯ¸«¤·¤¿¥ª¥é¥ó¥À¤Î°å»Õ¤Î̾)¡£»ÀÀ¥Þ¥ë¥¿¡¼¥¼(a-¥°¥ë¥³¥·¥¿¡¼¥¼¤È¤â¸À¤¦)·ç»¤Ë¤è¤ë¥°¥ê¥³¡¼¥²¥óÃßÀÑ¾É | ¾ïÀ÷¿§ÂÎÀ¡¢Ã±°ì°äÅÁ»Ò | * |
264 |
Glycogen storage disease IIIa Åü¸¶ÉÂIIIa·¿ |
´Î¼ðÂç¡¢¶ÚÎÏÄã²¼ |
Gene: AGL ¥³¥êÉ |
AR | * |
265 |
Glycogen storage disease » Åü¸¶É»·¿ |
±¿Æ°Ãæ¤Î¶ÚÄË(¤¿¤À¤·°ìµÙ¤ß¸å¤Ë¤Ï±¿Æ°Á°¤ËÌá¤ë¤Î¤ÇµÙ·Æ¤òÆþ¤ì¤ì¤Ð³¹Ô¤Ç¤¤ë)¡¢°×ÈèÏ«¡¢¶Ú¶¯Ä¾¡£±¿Æ°¸å¤Î¥ß¥ª¥°¥í¥Ó¥óÇ¢(Èó¾ï¤ËÇ»¤¤¿§)¡£ÍÏ·ì·¹¸þ¡¢¹â¥Ó¥ê¥ë¥Ó¥ó·ì¾É¡£·ìÀ¥¯¥ì¥¢¥Á¥ó¥¥Ê¡¼¥¼(CPK)¤Î¾å¾º¡£ |
Genes:PFKM ¿â°æÉÂ(ºÇ½é¤Ëɵ¤¤ÎÊó¹ð¤ò¤·¤¿¿â°æÂçºåÂç³Ø̾ÍÀ¶µ¼ø¤Ë°ø¤à)¡£¶Ú¥Û¥¹¥Û¥Õ¥ë¥¯¥È¥¥Ê¡¼¥¼·ç»¤Ë¤è¤ë¥ß¥ª¥Ñ¥Á¡¼ |
AR | * |
266 |
Goitre, familial ²È²À¹Ã¾õÁ£¼ð |
¹Ã¾õÁ£¤Î³ÈÂç¡¢¼ó¤ÎÁ°¤Î¼ð¤ì |
¹Ã¾õÁ£¼ð¤È¤Ï¹Ã¾õÁ£µ¡Ç½¤Î°Û¾ï¤¬´ØÏ¢¤·¤Æ¤¤¤ë¤¤¤Ê¤¤¤Ë´Ø¤ï¤é¤º¹Ã¾õÁ£¤¬³ÈÂ礵¤ì¤¿¾õÂÖ¤ÎÁí¾Î¡£ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395427/ ¹Ã¾õÁ£Âå¼Õ¤Î¸¶È¯ÀÀèÅ·°Û¾ï¤È·ì´Éȯã²áÄø¤Î·ç´Ù¤Î´ØÏ¢À2012ǯ¤Î»¨»ïJournal of the American Animal Hospital Association¡ÊVol. 48¡Ë¤Ë¸ø³«¤µ¤ì¤¿¸¦µæ ¡ÊÀ¸¸å4¡Á5¥õ·îÎð¤Î¥ê¥Ã¥¿¡¼8Ƭ¤Î¤¦¤Á3Ƭ¤Î»Ò¸¤¤ÎÊ¢Éô»ÒµÜðôÉôÎΰè¤Ëǧ¤á¤é¤ì¤¿Î¾Â¦Èé²¼¼ðáî¤Î³Æ¼ï¸¡ºº·ë²Ì¡Ë ¹Ã¾õÁ£¥Û¥ë¥â¥ó¤Î·ìÀ¶Ç»ÅÙ¤¬´ð½àÈÏ°Ï̤Ëþ¤Ç¤¢¤Ã¤¿¡¢ÂçÉôʬ¤¬Á£¤ÎÎΰè¤Ë½ÅÅ٤˳ÈÄ¥¤·¤¿°Û¾ï¤ÊÌ®´É¹½Â¤¤òͤ¹¤ë³ÈÂç¹Ã¾õÁ£¤ÈƱÄꤵ¤ì¤¿¡¢¹Ã¾õÁ£¼ð¤Î¸ºß¤ò½ü¤¤¤Æ¡¢¹Ã¾õÁ£µ¡Ç½Äã²¼¾É¤ÎÎ×¾²Ä§¸õ¤ò¼¨¤µ¤Ê¤«¤Ã¤¿¡¢1Ƭ¤ÏÆ°Ì®´É³«Â¸¾É¤òʻȯ¡¢¤Û¤« |
unknown | PL¥·¡¼¥×¥É¥Ã¥° |
Hyperadrenocorticism Éû¿ÕÈé¼Áµ¡Ç½Ð¶¿Ê¾É |
½é´ü¤Ï¿©Íߤä°û¿åÎ̤äÇ¢Î̤ÎÁý²Ã¡¢Ê¢ÉôËÄËþ¡¢º¸±¦ÂоݤÇáڤߤΤʤ¤Ã¦ÌÓ¤Ê¤É |
¥¯¥Ã¥·¥ó¥°¾É¸õ·²¡¢ÈéÉæ¿Å¸Àþ¾ò(¥Ò¥È¤ÎÇ¥¿±Àþ¤Î¤è¤¦¤Ê¤â¤Î)¤äÈéÉ椬Àȼå¤Ë¤Ê¤ë¤³¤È¤â¤¢¤ë¡£¢ÎÉû¿ÕÈé¼Áµ¡Ç½Äã²¼¥¢¥¸¥½¥óÉÂ(³°½ýÉô°Ì¤Ë¿§ÁÇÁý²Ã¤¬ÌÜΩ¤Ä) Dr. ¾®µÜ»³¤Îȼηưʪ¤Ø¤Î¤ä¤µ¤·¤¤¡ÊÍ¥¤·¤¤¡Ë½Ã°å³Ø¡Ö¸¤¤ÎÉû¿ÕÈé¼Áµ¡Ç½Ð¶¿Ê¾É¡Ê¸¤¤Î¥¯¥Ã¥·¥ó¥°¾É¸õ·²¡Ë (2005/5/14 ÂèÆó²ó²þÄû)¡× |
* | * | |
317 |
Hypercholesterolaemia ¹â¥³¥ì¥¹¥Æ¥í¡¼¥ë·ì¾É |
ÌܤΥեÁ¤ä¤Þ¤Ö¤¿¤ÎÆ⦴ޤàÌܤμþ°Ï¤Ë¾®¤µ¤¤»éËäΤǤ¤â¤Î¡¢Æ°Ì®¶¹ºõ¡¢Æ°Ì®¹Å²½¡¢µõ·ìÀ¿´¼À´µ¡Ê¶¹¿´¾É¡¢¿´¶Ú¹¼ºÉ¡Ë | ·ì±ÕÃæ¤ÎÁí¥³¥ì¥¹¥Æ¥í¡¼¥ëÃͤ¬¹â¤¤¥¿¥¤¥×¤Î»é¼Á°Û¾ï¾É¤Ç¤¤¤¯¤Ä¤«¤Î·¿¤¬¤¢¤ë¤¬ÂÎÆâ¤Î¥³¥ì¥¹¥Æ¥í¡¼¥ë¤ò±¿¤Ö¤¿¤á¤Î¼õÍÆÂΤäʬ²ò¹ÚÁǤη绤¬¼ç¡£¥¢¥¥ì¥¹ç§¤Ë¤â»éËü𤬤Ǥ¤¿¤ê¤½¤Î¼þ°Ï¤¬¼ð¤ì¤¿¤è¤¦¤ËÈî¸ü¤¹¤ë¾ì¹ç¤â¤¢¤ë¡£ Æ°Ì®¹Å²½¤Ê¤É¤Ë¤è¤ê¿´Â¡¤Ë¤Ï¤ê¤á¤°¤é¤µ¤ì¤¿´§Æ°Ì®¤Ë½½Ê¬¤Ê»ÀÁÇ¡¦¥¨¥Í¥ë¥®¡¼¤¬¹Ô¤ÅϤé¤Ê¤¤¾õÂÖ¤òµõ·ì¤È¤¤¤¤¡¢ µõ·ì¤¬°ì²áÀ¤À¤È¶¹¿´¾É¡¢´§Æ°Ì®¤¬´°Á´¤ËµÍ¤Þ¤ê¿´¶Ú¤¬²õ»à¤¹¤ë¤È¿´¶Ú¹¼ºÉ¡£¹Ã¾õÁ£µ¡Ç½Äã²¼¾É¡¢ÅüǢɡ¢¥Í¥Õ¥í¡¼¥¼¾É¸õ·²¡¢ÊĺÉÀ²«áդʤɤǤâ·ìÀ¶¥³¥ì¥¹¥Æ¥í¡¼¥ëÃͤϾ徺¤¹¤ë¡ÊÆó¼¡À¡Ë | * | ¥É¡¼¥Ù¥ë¥Þ¥ó¡¢¥í¥Ã¥È¥ï¥¤¥é¡¼¡¢¥³¥ê¡¼ |
325 |
Hyperlipidaemia ¹â»é·ì¾É |
Áê±þ¤Ë¿Ê¹Ô¤¹¤ë¤Þ¤Ç¾É¾õ¤¬¤Û¤È¤ó¤É̵¤¤¡£ç¹±ê¤ä¿´¶Ú¹¼ºÉ¤Ë»ê¤ë¤³¤È¤â¤¢¤ë¡£ | ·ìÃæ»é¼ÁÃͤ¬°Û¾ï¤Ë¿¤¤¾õÂÖ¡£»é¼Á°Û¾ï¾Édyslipidemia¤ò°ÊÁ°¤Ï¹â»é·ì¾É¤È¸À¤Ã¤¿¡£ | unknown | * |
326 |
Hyperlipoproteinaemia ¹â¥ê¥ÝÃÁÇò·ì¾É |
¹â»é·ì¾É¤ÈƱÍÍ¡¢´Î¼ð¡¢ç£¼ð¡¢·«¤êÊÖ¤¹Ê¢ÄËȯºî |
¥Ò¥È¤Ç¤Ï²«¿§¼ð¤¬¤Þ¤Ö¤¿¤äɪ¡¦É¨¡¦¿¬¡¦ÇØÃ桦µÓ¤ÎÁ°Â¦¡¢ÏӤθ妤ʤɤ˽ÐÍè¤ë¡£ç¹±ê¡£»à¤Ë»ê¤ë¤³¤È¤â¤¢¤ë¡£ ¥ê¥ÝÃÁÇò¤Ï»é¼Á¤¬·ìÞùÃæ¤Ë¸ºß¤¹¤ëÍÍÂ֤ǡ¢»é¼Á¤È¥¢¥Ý¥ê¥Ý¥¿¥ó¥Ñ¥¯¼Á¤¬·ë¹ç¤·¤¿¤â¤Î |
unknown | M¥·¥å¥Ê |
327 |
Hyperparathyroidism Éû¹Ã¾õÁ£µ¡Ç½Ð¶¿Ê¾É |
¸µµ¤¾ÃÄÀ¡¢¿Õ·ëÀС¢¿©ÍßÉÔ¿¶¡¦ÓÒÅÇ¡¦²¼Î¡(¾Ã²½ÀÄÙáç)¡¢ç¹±ê¡¢°×¹üÀÞÀ |
·ì±ÕÃæ¤Î¥«¥ë¥·¥¦¥àÇ»ÅÙ¤ò°ìÄê¤ÎÈÏ°ÏÆâ¤ËÄ´À᤹¤ëÉû¹Ã¾õÁ£¥Û¥ë¥â¥ó¤¬¾åÈé¾®ÂΤβá·ÁÀ®¤äÁ£¼ð¤¬¼ç¤Ê¸¶°ø¤Ç¡¢·ì±ÕÃæ¤Î¥«¥ë¥·¥¦¥à¤¬Àµ¾ï¤Þ¤¿¤Ï¤½¤ì°Ê¾å¤¢¤ë¤Î¤ËÉû¹Ã¾õÁ£¥Û¥ë¥â¥ó¤¬É¬Íװʾå¤Ë¤Ä¤¯¤é¤ì¤ë¤³¤È¤Çµ¯¤³¤ëɵ¤¡£ ·ò¹¯ÂΤǤϷì±ÕÃæ¤Î¥«¥ë¥·¥¦¥à¤¬¸º¤ë¤ÈÉû¹Ã¾õÁ£¥Û¥ë¥â¥ó¤¬Áý²Ã¤¹¤ë¤³¤È¤Ë¤è¤ê¹ü¤ËÃߤ¨¤é¤ì¤Æ¤¤¤ë¥«¥ë¥·¥¦¥à¤¬·ì±ÕÃæ¤ËÍϤ«¤·½Ð¤µ¤ì¤Æ¥«¥ë¥·¥¦¥àÇ»ÅÙ¤¬Àµ¾ï¤ËÌá¤ë»ÅÁȤߤˤʤäƤ¤¤ë¡£ ¿ÇÃÇ;¹â¢ª·ìÃ楫¥ë¥·¥¦¥àÇ»ÅÙ¤ÈÉû¹Ã¾õÁ£¥Û¥ë¥â¥ó¤ÈÇ¢Ã楫¥ë¥·¥¦¥àÇÓÝõÎÌ |
AD | ¿ |
328 |
Hyperphosphatasaemia ¹â¥¢¥ë¥«¥ê¥Û¥¹¥Õ¥¡¥¿¡¼¥¼·ì¾É |
̵¾É¾õ¤Þ¤¿¤ÏÓÒÅǤ䲼Ρ¤Ê¤É·Ú¤¤¾Ã²½´ï¾É¾õ | ¥¢¥ë¥«¥ê¥Û¥¹¥Õ¥¡¥¿¡¼¥¼(ALP¡á´Îµ¡Ç½¤Î»Øɸ¤Î¤Ò¤È¤Ä)¤È¤Ï¥¢¥ë¥«¥êÀ¤Î¾õ¶·²¼¤Ç¥ê¥ó»À¥¨¥¹¥Æ¥ë²½¹çʪ¤ò²Ã¿åʬ²ò¤¹¤ë¹ÚÁÇ¡£´Î¡¡¢¿Õ¡¡¢¹ü¡¢¾®Ä²¡¢ÂÛÈפʤɤË¿¤¯´Þ¤Þ¤ì¤ë¤Î¤Ç¤½¤ì¤é¤Î¡´ï¤¬¥À¥á¡¼¥¸¤ò¼õ¤±¤ë¤È·ì±ÕÃæ¤Ç¹âÃͤȤʤ롣¤¬¡¢²È²ÀÎÉÀ¹â¥¢¥ë¥«¥ê¥Û¥¹¥Õ¥¡¥¿¡¼¥¼·ì¾É¤Ç¤Ï¡¢Î×¾²¡¢Êü¼ÍÀþ³ØŪ¡¢À¸²½³ØŪɾ²Á¤Ï¾¤Î°Û¾ï½ê¸«¤òǧ¤á¤Ê¤¤¤Î¤Ë·ìÀ¶¥¢¥ë¥«¥êÀ¥Û¥¹¥Õ¥¡¥¿¡¼¥¼¡ÊALP¡Ë¤ÎñÆȹâÃ͡ʾ®Ä²·¿ALP¤ËͳÍ褹¤ë·ìÀ¶ALP¤Î°Û¾ï¹âÃ͡ˤ¬¸«¤é¤ì¤ë¡¢¤È¤¤¤¦¸¦µæ | unknown | ¥Ï¥¹¥¡¼ |
331 |
Hypertrichosis ¿ÌÓ¾É |
¿Ë¶â¾õ¡¢ÍÓÌÓ¾õ¡¢ÇȾõ¤Ê¤É¤ÎÆÈÆäʰ۾ï¤Ê¥³¡¼¥È | 1¤Ä¤ÎÌÓÊñ¤«¤éÊ£¿ô¤ÎÌÓ¤¬È¯À¸¤¹¤ë¡£¤³¤Î°Û¾ï¤Ï¹¶·âÀ¤ä¿ư¡¦³Ø½¬¾ã³²¤òȼ¤¤¤·¤Ð¤·¤ÐÌ©Àܤ˿åƬ¾É¤äÃæ¿õ¿À·Ð·Ï¤Ë±Æ¶Á¤òÍ¿¤¨¤ëɵ¤¤Ë´ØÏ¢ÉÕ¤±¤é¤ì¤Æ¤¤¤ë | unknown | ¥´¥ë |
332 |
Hypertriglyceridaemia ¹â¥È¥ê¥°¥ê¥»¥ê¥É·ì¾É |
°²½¤·¤Æ¤«¤é¤Î¿©ÍßÉÔ¿¶¡¢¾Ã²½´ï¾É¾õ¡¢ç¹±ê | ·ì±ÕÃæ¤Ë´Þ¤Þ¤ì¤ë»é¼Á¤¬²á¾ê¤¢¤ë¤¤¤ÏÉÔ¤¹¤ë»é¼Á°Û¾ï¾É(°ÊÁ°¤Ï¹â»é·ì¾É¤È¸Æ¤ó¤À)¤Î¤¦¤Á·ì±ÕÃæ¤ËÃæÀ»éËÃ(¥È¥ê¥°¥ê¥»¥ê¥É)¤¬Â¿¤¯Â¸ºß¤¹¤ë¥¿¥¤¥×¤Î»é¼Á°Û¾ï¾É¡£¥ß¥Ë¥·¥å¥Ê¤Î¾ì¹ç¤Ï¥¤¥ó¥¹¥ê¥óÄñ¹³À¤È´ØÏ¢¤·¤Æ¤¤¤ë | unknown | M¥·¥å¥Ê |
333 |
Hypoadrenocorticism Éû¿ÕÈé¼Áµ¡Ç½Äã²¼¾É |
¿°û¡¢¿©ÍßÉÔ¿¶¡¢¿´Çï¿ôÄã²¼¡¢ÄãÂβ¹¡¢¿Ì¤¨¡¢²¼Î¡¡¢ÓÒÅÇ¡¢ÂνŸº¾¯ | Éû¿Õ¤«¤éʬÈ礵¤ì¤ë¥Û¥ë¥â¥ó¤Î·ç˳¡¢¥¢¥¸¥½¥óÉ | unknown | ¥´¥ë¡¢¥Ó¥¢¥Ç¥£¡¢G¥·¥§¥Ñ |
334 |
Hypoadrenocorticism, primary ¸¶È¯ÀÉû¿ÕÈé¼ÁÄã·ÁÀ® |
¿©ÍßÉÔ¿¶¡¢¶ÚÎÏÄã²¼¡¢Ìµµ¤ÎÏ | ¸¶È¯À¤È¤ÏºÇ½é¤Ë¤½¤ÎÉô°Ì¤Ëȯ¾É¤¹¤ë¡¢¤È¤¤¤Ã¤¿°ÕÌ£¡£¢ÎÆó¼¡À¡£¸¶È¯À¤ÎËýÀÉû¿ÕÈé¼Áµ¡Ç½Äã²¼¾É¤Ë¤ÏÀèÅ·À¤Î¤â¤Î¤È¸åÅ·À¤Î¤â¤Î¤¬Â¸ºß¤·¡¢ÀèÅ·À¤Î¤â¤Î¤Ï¥¢¥¸¥½¥óɤȤÏÆÈΩ¤·¤¿¼À´µÃ±°Ì¤È¤·¤Æ°·¤ï¤ì¤ë¤è¤¦¤Ë¤Ê¤Ã¤¿¡£¤³¤Î¤¿¤á¡¢¥¢¥¸¥½¥óɤϸåÅ·À¤ÎÀ®°ø¤Ë¤è¤ëÉÂÂÖ¤òÁí¾Î¤¹¤ëÍѸì¤È¤·¤ÆÍѤ¤¤é¤ì¤Æ¤¤¤ë | unknown | ¿ |
335 |
Hypocatalasia Ä㥫¥¿¥é¡¼¥¼¾É |
»õ¼þ°ÏÁÈ¿¥¤Î¿Ê¹ÔÀ²õáÔÀÉÂÊÑ | ÀèÅ·À¤Î°äÅÁŪ¹ÚÁǷ绤ÎÂåɽÎã¡£ÂÎÆâÃæ¤Î¥«¥¿¥é¡¼¥¼¤¬ÉÔ¤·¡¢²á»À²½¿åÁǤ¬Ê¬²ò¤Ç¤¤Ê¤¯¤Ê¤ëɵ¤¡£¹â¸¶»áÉÂ(Takahara's disease)¡£Ìµ¥«¥¿¥é¡¼¥¼¾É¤ÏAcatalasia |
ñ°ì°äÅÁ»Ò ¤ª¤½¤é¤¯AR |
¥Ó¡¼¥°¥ë |
337 |
Hypolipoproteinaemia Äã¥ê¥ÝÃÁÇò·ì¾É |
̵¾É¾õ¤«¤é»éËää»éÍÏÀ¥Ó¥¿¥ß¥óE¡¢K¡¢AµÛ¼ý¾ã³²¤Ë¤è¤ë²¼Î¡¡¢¾®¤Ö¤ê¡¢Î®»º¡¢¹â·ì°µ¡¢Ç¾Â´Ãæ¡¢ÆÍÁ³»à | ¹â»é·ì¾É¡£Áí¥³¥ì¥¹¥Æ¥í¡¼¥ë¹âÃÍ | unknown | M¥·¥å¥Ê |
340 |
Hypoparathyroidism Éû¹Ã¾õÁ£µ¡Ç½Äã²¼¾É¡¢¾åÈé¾®ÂÎÄã²¼¾É |
¥Æ¥¿¥Ë¡¼(»Í»è¤Îáã¤ì)¡¢¤±¤¤¤ì¤óȯºî¡¢Êâ¹Ô°Û¾ï | Éû¹Ã¾õÁ£¥Û¥ë¥â¥ó(PTH)¤ÎÉÔ¤ò¸¶°ø¤È¤·¤¿Ä㥫¥ë¥·¥¦¥à·ì¾É¡¢¹â¥ê¥ó·ì¾É¤Ë¤è¤Ã¤Æ¼ï¡¹¤Î¾É¾õ¤ò¼¨¤¹Âå¼ÕÀ¼À´µ | * | * |
343 |
Hypothyroidism ¹Ã¾õÁ£µ¡Ç½Äã²¼¾É |
¸µµ¤¾ÃÄÀ¡¢ÂνÅÁý²Ã¡¢¹¶·âÀ¡¢Êâ¹Ô»þ¤Î¤³¤ï¤Ð¤ê¡¢º¸±¦ÂоÎÀæÌÓ¡¢¤Æ¤ó¤«¤óȯºî¡¢Ç´±Õ¿å¼ð |
Genes:TPO Á´¿È¤Î¥¨¥Í¥ë¥®¡¼ÍøÍѤòÂ¥¤¹¹Ã¾õÁ£¥Û¥ë¥â¥ó¤ÎʬÈçÎÌ(³èÀ)¤¬ÉÔ½½Ê¬¤È¤Ê¤ëÆâʬÈç¼À´µ¡£¤è¤Ã¤Æ¾É¾õ¤Ë¤«¤Ê¤ê¸ÄÂκ¹¤¬¤¢¤ë¡£¹Ã¾õÁ£¼«ÂΤÎÌäÂê¤Ë¤è¤ëʬÈçÉÔÁ´¤Ï¸¶È¯À¹Ã¾õÁ£µ¡Ç½Äã²¼¾É¡¢¹Ã¾õÁ£»É·ã¥Û¥ë¥â¥ó(TSH)ÉÔ¤ˤè¤ëʬÈçÉÔÁ´¤ÏÆó¼¡À¹Ã¾õÁ£µ¡Ç½Äã²¼¾É¡¢¹Ã¾õÁ£»É·ã¥Û¥ë¥â¥óÊü½Ð¥Û¥ë¥â¥ó(TRH)¤ÎÄã²¼¤Ë¤è¤ëTSH¤È¹Ã¾õÁ£¥Û¥ë¥â¥ó¤ÎʬÈçÉÔÁ´¤ò»°¼¡À¹Ã¾õÁ£¥Û¥ë¥â¥óÄã²¼¾É¤È¸Æ¤Ö |
AR | ¿ |
344 |
Hypothyroidism , primary ¸¶È¯À¹Ã¾õÁ£µ¡Ç½Äã²¼¾É |
Ʊ¾å | ¼«¸ÊÌȱ־㳲¤Ë¤è¤Ã¤Æ¹Ã¾õÁ£¤¬¹¶·â¤µ¤ì¤ë¥Ò¥È¤Î¶¶ËÜɤǤϹþõÁ£¤ÎËýÀ±ê¾É¤«¤éµ¡Ç½Äã²¼¤Ë¤¤¤¿¤ê¡¢¥è¥¦ÁÇÉÔ¤ǥۥë¥â¥ó»ºÀ¸¤¬³²¤µ¤ì¤ë¤Ê¤É¤¬¸¶È¯À¡£¹Ã¾õÁ£¤Îµ¡Ç½¤Ï¼ç¤Ë»ë¾²²¼Éô-²¼¿âÂÎ-¹Ã¾õÁ£·Ï¤¬Àµ¾ï¤Ç¤Ê¤±¤ì¤Ð¤Ê¤é¤Ê¤¯¡¢²¼¿âÂΤμðáç¤ä·ì´É¾ã³²¤Ê¤É¤¬Æó¼¡À¡¢»°¼¡À¤ÎÄã²¼¾É¤Ë¤Ä¤Ê¤¬¤ë | unknown | * |
345 |
Hypotrichosis ÉÏÌӾɡ¢Ë³ÌÓ¾É |
°Ê²¼¤Î¸¤¼ï¤Ç̵ÌÓ¤Ïñ°ì°äÅÁ»ÒºÂ¤Î¥Ø¥Æ¥íÀܹç¤Ç¤¢¤ë | ¥Á¥ã¥¤¥Ë¡¼¥º¥¯¥ì¥¹¥Æ¥Ã¥É¥É¥Ã¥°¡¢¥á¥¥·¥«¥ó¥Ø¥¢¥ì¥¹¥É¥Ã¥°¡¢¥Ú¥ë¡¼¥Ó¥¢¥ó¥Ø¥¢¥ì¥¹¥É¥Ã¥°¤Ê¤É¸²À¥Ø¥¢¥ì¥¹¼ï¤Î̵ÌÓ | ¾ïÀ÷¿§ÂÎÀ | ¸²À¥Ø¥¢¥ì¥¹ |
346 |
Hypotrichosis, recessive ÎôÀÉÏÌӾɡ¢Ë³ÌÓ¾É |
°Ê²¼¤Î¸¤¼ï¤Ç̵ÌÓ¤Ïñ°ì°äÅÁ»ÒºÂ¤Î¥Û¥âÀܹç¤Ç¤¢¤ë |
Gene: SGK3 ¥¢¥á¥ê¥«¥ó¤Ø¥¢¥ì¥¹¥Æ¥ê¥¢¡Ê¥é¥Ã¥È¥Æ¥ê¥¢¤ÎÆÍÁ³ÊÑ°Û¸ÄÂΡˡ££³Âç̵ÌÓ¼ï¤È¤Ï°Û¤Ê¤ë¾ïÀ÷¿§ÂÎÀøÀ¥Ø¥¢¥ì¥¹ |
AR | ÀøÀ¥Ø¥¢¥ì¥¹ |
358 |
Inborn error of hepatic metabolism *´ÎÀÀèÅ·ÀÂå¼Õ°Û¾ï |
¾ã³²¤Î¤¢¤ëʪ¼Á¤Ë¤è¤ë | ÀèÅ·ÀÂå¼Õ°Û¾ï¤Î¼£ÎŤΤ¿¤á¤Î°Û·¿´Î°Ü¿¢¤Î¸¦µæ | unknown | * |
372 |
Krabbe disease ¥¯¥é¥Ã¥ÙÉ |
´Ë¤ä¤«¤Ê¿Ê¹ÔÀ¤Î¿Ì¤¨¡¢±¿Æ°¼ºÄ´¡¢Ëãáã¡¢¾®Ç¾µ¡Ç½¾ã³² |
Genes:GALC ¥é¥¤¥½¥¾¡¼¥à¼À´µ(¥¹¥Õ¥£¥ó¥´»é¼Á¾É)¡£¾ïÀ÷¿§ÂÎÎôÀ°äÅÁ¤Îæ¿ñÀ¿À·ÐÊÑÀ¼À´µ¡¢µåÍͺÙ˦Çò¼Á°à½Ì¾É |
AR | ¥¦¥§¥¹¥Æ¥£¡¢¥±¥¢¥ó¡¢I¥»¥Ã¥¿¡¼¡¢¥±¥ë¥Ô¡¼¡¢¥À¥ë¥á¥·¥¢¥ó |
373 |
L-2-hydroxyglutaricacidemia ?L-2-¥Ò¥É¥í¥¥ª¥¥·¥°¥ë¥¿¥ë»ÀÇ¢¾É |
Àº¿À±¿Æ°È¯Ã£ÃÙÂÚ¡¢¤±¤¤¤ì¤óȯºî¡¢±¿Æ°¼ºÄ´¡¢ÃÔÊò |
Genes: L2HGDH ÀèÅ·ÀÂå¼Õ°Û¾ï¡¢Ç¢Ãæ͵¡»À°Û¾ï(Ç¢¤ä·ì±Õ¤Ê¤ÉL-2-¥Ò¥É¥í¥¥ª¥¥·¥°¥ë¥¿¥ë»À¤Î¾å¾º)¡£¼ç¤ËÂçǾÈé¼Á¡¢»ë¾²¡¢¾®Ç¾¡¢Ç¾´´¤Î³¥Çò¼Á¤¬³¤Ìʾõ¤ËÊѲ½¤¹¤ë |
AR | ¥¹¥¿¥Ã¥Õ¥£¡¼¡¢¥¦¥§¥¹¥Æ¥£ |
381 |
Leucodystrophy Çò¼Á¥¸¥¹¥È¥í¥Õ¥£ |
¿åƬ¾É¡¢Ç¾ÀÔ¿ñ¤Î¿À·Ð¾É¾õ |
Gene: CYTB ³¤ÌʾõÊÑÀ·¿Çò¼Á¥¸¥¹¥È¥í¥Õ¥£ ¡¢¥í¥¤¥³¥¸¥¹¥È¥í¥Õ¥£¡¢Ç¾Çò¼ÁÊÑÀ¾É¡¢³¤ÌÊǾÀÔ¿ñ¾É¡£¤ª¤½¤é¤¯¥Ò¥È¤Î¥«¥Ê¥Ð¥óÉÂCanavan disease¤Ë¶á¤¤¾É¾õ¤Î¤è¤¦¤À¡£ ǾÀÔ¿ñ¤ÎÇò¼Á¤Ë¹ÈϰϡʤӤޤóÀ¡Ë¤Ê½ÅÅ٤γ¤ÌʾõÊÑÀ¤¬¸«¤é¤ì¤ë¡£Áá´üȯ¾É¡¦Í½¸åÉÔÎÉ |
¥ß¥È¥³¥ó¥É¥ê¥¢°äÅÁ | ¥À¥ë¡¢¥·¥§¥ë¥Æ¥£ |
388 |
Lipidosis ¥ê¥Ô¥É¡¼¥·¥¹ |
ÌÓ¿§¤Î漺¡¢¤«¤¿¤Þ¤Ã¤¿È´¤±ÌÓ¡¢ÁƤ¤¥ª¡¼¥Ð¡¼¥³¡¼¥È¤ÎÁÓ¼º¡¢ÈéÉæ¤Î¹õ¤º¤ß¡¢À®Ä¹ÉÔÎÉ¡¢¸¶°øÉÔÌÀ¤ÎÓÒÅǤ¬Â¿¤¤ | »é¼ÁÂå¼Õ°Û¾ï¡£»é¼Á¡Êlipid)¤¬°Û¾ïÃßÀÑ¡Êosis)¤¹¤ëɵ¤¤ÎÁí¾Î¡£¥é¥¤¥½¥¾¡¼¥àÉÂ(GM£±¥¬¥ó¥°¥ê¥ª¥·¥É¡¼¥·¥¹¡¢¥´¡¼¥·¥§É¡¢¥¯¥é¥Ã¥ÙɤʤÉ)¡£ ¤³¤Î¹àÌܤǤÏLipidosis, follicular ßÉ˦À¥ê¥Ô¥É¡¼¥·¥¹(ÌÓÊñÆâ¤Ë»éËä¬ÃßÀÑ)¤ÎÀâÌÀ¤Î¤è¤¦¤À | unknown | * |
397 |
Lysosomal storage disease ¥é¥¤¥½¥¾¡¼¥àÃßÀÑÉ |
·ç»¹ÚÁǤˤè¤Ã¤Æ¾É¾õ¤Ï¤µ¤Þ¤¶¤Þ | ¥é¥¤¥½¥¾¡¼¥à¡ÊºÙ˦Æâ¾®´ï´±¡Ë¤Ë´ØÏ¢¤¹¤ë¹ÚÁǤη绤ˤè¤êʬ²ò¤µ¤ì¤ë¤Ù¤Êª¼Á¤¬Ï·ÇÑʪ¤È¤·¤ÆÂÎÆâ¤ËÃßÀѤµ¤ì¤ëÂå¼Õ°Û¾ï¾É¤ÎÁí¾Î¡£¥ê¥½¥½¡¼¥à | unknown | * |
409 |
Menkes syndrome ¥á¥ó¥±¥¹É |
ȯãÃٱ䡢ÄãÂβ¹¡¢¤±¤¤¤ì¤óȯºî¡¢¶ÚÎÏÄã²¼¡¢½ÌÌÓ |
Genes:TP53,APRT,CKM,PKLR,CSF1R,ATP7A XÀ÷¿§ÂÎÏ¢º¿ÎôÀ°äÅÁ¤Ë¤è¤ëƼÂå¼Õ°Û¾ï¾É |
XR | * |
410 |
Metabolizer of a congitive enhancer ???Ìô¤ÎÂå¼ÕǽÎÏ |
* |
Gene: CYP1A2 ¥¿¥ó¥Ñ¥¯·ç»¾É¤Î¤³¤È¤Î¤è¤¦¤À¡£Ç§ÃÎÁý¶¯ºÞAC-3933¤òÂå¼Õ¤¹¤ëǽÎϤο·¿¤ÎÊó¹ð |
unknown | ¥Ó¡¼¥°¥ë |
418 |
Mucopolysaccharidosis I ¥à¥³Â¿Åü¾Éµ·¿ |
¥à¥³Â¿Åü¾É»²¾È |
Gene: FGFRL1 6¥ö·î¤«¤é1ºÐ¤Çȯ¾É¡£ ¦Á-L-iduronidase·ç»¤Ë¤è¤ë¥Ç¥ë¥Þ¥¿¥óβ»À¤È¥Ø¥Ñ¥é¥óβ»À¤ÎÃßÀÑ¡£µ·¿¤Ï¤µ¤é¤Ë½Å¾É·¿¤Î¥Ï¡¼¥é¡¼¾É¸õ·²Hurler syndrome¡¢Ãæ´Ö·¿¤Î¥Ï¡¼¥é¡¼-¥·¥ã¥¤¥¨¾É¸õ·²Hurler-Scheie syndrome¡¢·Ú¾É·¿¤Î¥·¥ã¥¤¥¨¾É¸õ·² Scheie syndrome¤ËʬÎव¤ì¤ë¡£ |
AR | * |
419 |
Mucopolysaccharidosis ¶ ¥à¥³Â¿Åü¾É¶·¿ |
Àå¤ÎÈîÂç¡¢Áû²»¸ÆµÛ¡¢µ¤Æ»´¶À÷¡¢´Î磼𡢹üÊѲ½¡¢¤Ä¤Þ¤Å¤¡¢»Í»è¤ò¸ØÄ¥¤¹¤ë¤è¤¦¤ÊÊâ¤Êý¡¢³ÑË캮Âù¡¢´ØÀá¤Î²ÄÆ°ÀÄã²¼(¤¹¤Ù¤Æ¿Ê¹ÔÀ) | iduronate-2-sulfatase·ç»¤Ë¤è¤ë¥Ø¥Ñ¥é¥óβ»À¤È¥Ç¥ë¥Þ¥¿¥óβ»À¤ÎÃßÀÑ¡£Ç¢Ãæ¤Ë¥à¥³Â¿Åü¤Ç¤¢¤ë¥Ç¥ë¥Þ¥¿¥óβ»À¡¢¥Ø¥Ñ¥é¥óβ»À¤¬Â¿Î̤ËÇÓÝõ¤µ¤ì¤ë¡£¥Ï¥ó¥¿¡¼¾É¸õ·²Hunter syndrome | x-linked | * |
420 |
Mucopolysaccharidosis ·A ¥à¥³Â¿Åü¾É·A·¿ |
¿ç̲¾ã³²¡¢È¯Ã£Ãٱ䡢¤±¤¤¤ì¤óȯºî¡¢¶½Ê³¡¢¹¶·âÀ¡¢Êâ¹ÔÉÔǽ |
Genes:SGSH ·ç»¹ÚÁǤΰ㤤¤Ë¤è¤êMPS III-A·¿¡ÁIII-D·¿¤Î4¤Ä¤Î°¡·¿¤ËʬÎव¤ì¤ë¤¬¡¢Î×¾²¾É¾õ¤Ï¤Û¤È¤ó¤ÉƱ¤¸¡£½ÅÅÙ¤ÎÀº¿Àȯã¤ÎÃÙÂÚ¤¬¼ç¾É¾õ¤Ç¤¢¤ê¡¢¹ü¡¦´ØÀá°Û¾ï¤ä´Î磼ð¤È¤¤¤Ã¤¿¾É¾õ¤Ï·ÚÅÙ¡£¥µ¥ó¥Õ¥£¥ê¥Ã¥Ý¾É¸õ·²Sanfilippo syndrome |
AR | ¥À¥Ã¥¯¥¹¡¢NZ¥Ï¥ó¥¿¥¦¥§¥¤ |
421 |
Mucopolysaccharidosis ·B ¥à¥³Â¿Åü¾É·B·¿ |
Ʊ¾å |
Genes: NAGLU ·ç»¹ÚÁǤÏIII-B·¿¡§¦Á-N-¥¢¥»¥Á¥ë¥°¥ë¥³¥µ¥ß¥Ë¥À¡¼¥¼ |
AR | ¥¹¥¥Ã¥Ñ¡¼¥ |
422 |
Mucopolysaccharidosis º ¥à¥³Â¿Åü¾Éº·¿ |
¿åƬ¾É¡¢¶»¹ü´ñ·Á |
Genes: ARSB N-acetylgalactosamine-4-sulfatase(N-¥¢¥»¥Á¥ë¥¬¥é¥¯¥È¥µ¥ß¥ó-4-¥¹¥ë¥Õ¥¡¥¿¡¼¥¼)·ç»¤Ë¤è¤ë¥Ç¥ë¥Þ¥¿¥óβ»À¤ÎÃßÀÑ¡£¥Ï¡¼¥é¡¼¾É¸õ·²¤ÈƱÍͤξɾõ¡£ ¥Þ¥í¥È¡¼¡¦¥é¥ß¡¼¾É¸õ·²Maroteaux-Lamy syndrome |
AR | ¥ß¥Ë¥Ô¥ó¡¢Ç |
423 |
Mucopolysaccharidosis » ¥à¥³Â¿Åü¾É»·¿ |
4½µÎð¤Çû¤¯ÂÀ¤¤´é¡¦¡¦²£Êý¸þ¤Ë¹¤¤¶»¡¦Ä㤤¼ªÉÕ¤¡¢8½µÎð¤Ç¤Ó¤Þ¤óÀ³ÑË캮Âù¡¢9½µÎð¤Ç¤Ï²áÅÙ¤ËÂ礤ÊƬÉô¡¦¤½¤Î¸¤¼ï¤ÎÄ̾ï¤Î»Ò¸¤¤ÎȾʬÄøÅÙ¤ÎÂ礤µ |
Genes:GUSB ¦Â-glucuronidase·ç»¤Ë¤è¤ë¥à¥³Â¿ÅüÎà¤ÎÁÈ¿¥ÆâÃßÀÑ¡£¥¹¥é¥¤É¡¢¥¹¥é¥¤¾É¸õ·²Sly syndrome |
AR | G¥·¥§¥Ñ |
482 |
Neuronal ceroid lipofuscinosis, 1 ¿À·Ð¥»¥í¥¤¥É¥ê¥Ý¥Õ¥¹¥Á¥ó¾É1·¿ Ä̾ÎCL¾É |
À¸¸å7¥ö·îº¢¤«¤é9¥ö·îº¢¤Þ¤Ç¤Ë¹ÔÆ°¤ÎÊѲ½¡¢¿À·Ð²áÉÒ¡¢¸«Åö¼±¾ã³²¡¢±¿Æ°¼ºÄ´¡¢Ã¦ÎÏ´¶¡¢¸å׿¾É¡¢Êâ¹Ô¤Î¹äÀ¡¢À©¸æÉÔǽ¤Ê¥ê¥º¥ß¥«¥ë¤ÊƬ¤ÎÆ°¤¡¢»ë³Ð¾ã³²(ÌÖËì·ì´É¤ÎÊÑÀ) |
Genes:PPT1 ¥é¥¤¥½¥¾¡¼¥à¼À´µ¡£NCL1¤¬Ãø¤·¤¯·ç»¤·¥Ñ¥ë¥ß¥È¥¤¥ë¥×¥í¥Æ¥¤¥ó¥Á¥ª¥¨¥¹¥Æ¥é¡¼¥¼¡ÊPPT1¡Ë¤Î³èÆ°¤Ë¤è¤Ã¤Æ°ú¤µ¯¤³¤µ¤ì¤ë¥À¥Ã¥¯¥¹¥Õ¥ó¥È¤Î°äÅÁÀ¼À´µ |
AR | ¥À¥Ã¥¯¥¹¤Î¤ß |
483 |
Neuronal ceroid lipofuscinosis, 10 ¿À·Ð¥»¥í¥¤¥É¥ê¥Ý¥Õ¥¹¥Á¥ó¾É10·¿ Ä̾ÎCL¾É |
2ºÐÁ°¤«¤é¬Äê²áÂç¾É¡¢Â¬Äê¾ã³²¡¢Ëãáã¡¢±¿Æ°¼ºÄ´¡¢¤ª¤è¤Ó¿Ê¹ÔÀÀº¿À±¿Æ°¤ÎÊÑÀ |
Genes:CTSD ¥é¥¤¥½¥¾¡¼¥à¼À´µ¡£Â¾¤ÎCLɤ˸«¤é¤ì¤Æ¤¤¤ëǾµ¡Ç½¾ã³²¤ä¼ºÌÀ¤Ïµ¯¤³¤é¤Ê¤¤¤¬7ºÐ¤Þ¤Ç¤Ë¤Ï»àË´ |
AR | ¥¢¥á¥ê¥«¥ó¥Ö¥ë¥É¥Ã¥°¤Î¤ß |
484 |
Neuronal ceroid lipofuscinosis, 12 ¿À·Ð¥»¥í¥¤¥É¥ê¥Ý¥Õ¥¹¥Á¥ó¾É12·¿ Ä̾ÎCL¾É |
ÃæÄøÅ٤λëÎϾ㳲¡¢¹ÔÆ°¤ÎÊѲ½¡¢Ç§Ãε¡Ç½¤ÎÄã²¼¡¢¾®Ç¾¼ºÄ´¡¢ÃÔÊò¡¢¤Æ¤ó¤«¤óÍÍȯºî¡¢¿À·Ð²áÉÒ¡¢¹¶·âÀ¡¢µ²±ÁÓ¼º¡¢»É·ã¤ËÂФ¹¤ë²áÉÒÀ¡¢¿Ì¤¨ |
Genes: ATP13A2 ¥é¥¤¥½¥¾¡¼¥à¼À´µ¡£4ºÐ¡Á6ºÐ¤Ëȯ¾É¡¢È¯¾É¸å¤ÏÁá´ü»àË´ |
AR | ¥Á¥Ù¥¿¥ó¥Æ¥ê¥¢ |
485 |
Neuronal ceroid lipofuscinosis, 2 ¿À·Ð¥»¥í¥¤¥É¥ê¥Ý¥Õ¥¹¥Á¥ó¾É2·¿ Ä̾ÎCL¾É |
¿Ê¹ÔÀ¤Î»ëÎÏÄã²¼¡¢¶¼°Ò¤Î±þÅú¡¢Æ¬Éô¤Î¿¶Àï¡¢¥ß¥ª¥¯¥í¡¼¥Ì¥¹¡¢¾®Ç¾À±¿Æ°¼ºÄ´¡¢Â¿Æ°¡¢¹¶·âÀÁý²Ã¡¢°ÕÌ£¤¬¤ï¤«¤é¤Ê¤¤Ëʤ¨ |
Genes: ¥é¥¤¥½¥¾¡¼¥à¼À´µ¡£À¸¸å6¡Á7¥ö·î¤Ë¿Ê¹ÔÀ¤Î»ëÎϾ㳲¤¬»Ï¤Þ¤ë¡¢8¥ö·îº¢¤Ë¥ß¥ª¥¯¥í¡¼¥Ì¥¹¤Æ¤ó¤«¤ó¡¦Æ¬Éô¿¶Àï¡¢9¥ö·îº¢¤«¤é¾®Ç¾À±¿Æ°¼ºÄ´¡¢µÞ®¤Ë¿Ê¹Ô¤·¤Æ1ºÐ¤Þ¤Ç¤Ë»àË´ ¥Ò¥ÈCLN2¤Î¥ª¥ë¥½¥í¥°(¶¦ÄÌÁÄÀè¤ò»ý¤Ä°Û¼ï´Ö¤ÎÁêƱ°äÅÁ»Ò)¡¡ |
AR | ML¥À¥Ã¥¯¥¹ |
486 |
Neuronal ceroid lipofuscinosis, 4A ¿À·Ð¥»¥í¥¤¥É¥ê¥Ý¥Õ¥¹¥Á¥ó¾É4A·¿ Ä̾ÎCL¾É |
¿Ê¹ÔÀ»ëÎϾ㳲¡¢¹ÔÆ°¤ÎÊѲ½¡¢Àº¿À¤Î°²½¡¢Ç§Ãα¿Æ°¤ÎÊÑÀ¡¢±¿Æ°¼ºÄ´¡¢¤Æ¤ó¤«¤óÍÍȯºî |
Genes: ¥é¥¤¥½¥¾¡¼¥à¼À´µ¡£5ºÐ¤Ê¤ÉÃÙ¤¯¤Ë¾É¾õ¤¬½Ð¤ë¤¬È¯¾É¸å¤Ï»àË´¡£2010ǯ¤ÎÄ´ºº¤Ç¤Ï¥¢¥á¥ê¥«¤È¥Õ¥é¥ó¥¹¤Î¥¢¥à¥¹¥¿¤Î50%¤¬¥¥ã¥ê¥¢¡¼¤Ç¤¢¤Ã¤¿¡£9ÈÖÀ÷¿§ÂÎñ°ì¤ÎÎΰ衩Kufs' disease»²¾È |
AR | ¥¢¥á¥ê¥«¥ó¥¹¥¿¥Ã¥Õ¥©¡¼¥É¥·¥ã¡¼¥Æ¥ê¥¢¤Î¥Õ¥é¥ó¥¹·ìÅý |
487 |
Neuronal ceroid lipofuscinosis, 5 ¿À·Ð¥»¥í¥¤¥É¥ê¥Ý¥Õ¥¹¥Á¥ó¾É5·¿ Ä̾ÎCL¾É |
¿Ê¹ÔÀ»ëÎϾ㳲¡¢Â¿Æ°¡¢Ç§Ãξɡ¢¹¶·âÀ¡¢¶¨Ä´¤ÎÁÓ¼º¡¢±¿Æ°¼ºÄ´ |
Genes:cln5 ¥é¥¤¥½¥¾¡¼¥à¼À´µ¡£2ºÐÁ°¸å¤Çȯ¾É¤·¡¢3ºÐ¤Þ¤Ç¤Ë»àË´ |
AR | ¥Ü¡¼¥À¡¼¥³¥ê¡¼ |
488 |
Neuronal ceroid lipofuscinosis, 6 ¿À·Ð¥»¥í¥¤¥É¥ê¥Ý¥Õ¥¹¥Á¥ó¾É6·¿ Ä̾ÎCL¾É |
¿Ê¹ÔÀ»ëÎϾ㳲¤Î¸å¼ºÌÀ¡¢Ç§Ãα¿Æ°¤ÎÊÑÀ¡¢Àû²ó¡¢¶¨Ä´±¿Æ°¼ºÄ´ |
Gene: CLN6
¥é¥¤¥½¥¾¡¼¥à¼À´µ¡£È¯¾ÉǯÎð¤Ï2ºÐÁ°¤¯¤é¤¤ |
AR | A¥·¥§¥Ñ |
489 |
Neuronal ceroid lipofuscinosis, 7 ¿À·Ð¥»¥í¥¤¥É¥ê¥Ý¥Õ¥¹¥Á¥ó¾É7·¿ Ä̾ÎCL¾É |
* |
Genes:CLN8 ¥é¥¤¥½¥¾¡¼¥à¼À´µ |
AR | ¥Á¥ã¥¤¥¯¥ì |
490 |
Neuronal ceroid lipofuscinosis, 8 ¿À·Ð¥»¥í¥¤¥É¥ê¥Ý¥Õ¥¹¥Á¥ó¾É8·¿ Ä̾ÎCL¾É |
¿Ê¹ÔÀ»ëÎϾ㳲¡¢¤Æ¤ó¤«¤óÍÍȯºî¡¢¿À·Ð¾ã³² |
Genes:CLN8 ¥é¥¤¥½¥¾¡¼¥à¼À´µ¡£È¯¾É¸åÁá´ü»àË´ |
AR | E¥»¥Ã¥¿¡¼ |
491 |
Neuronal Ceroid Lipofuscinosis, generic ¿À·Ð¥»¥í¥¤¥É¥ê¥Ý¥Õ¥¹¥Á¥ó¾É Ä̾ÎCL¾É |
°Û¾ï¹ÔÆ°¡¢Ç§Ãξɡ¢»ëÎϤÎÄã²¼¡¢±¿Æ°¾ã³²¤äáÛڻȯºî¡¢Áá´ü»àË´ |
Genes:cln5,CLN8 ¥é¥¤¥½¥¾¡¼¥à¼À´µ¡£CLɤΤޤȤá¤Î¤è¤¦¤Ê¹àÌÜ |
AR | ¥»¥Ã¥¿¡¼¡¢¥Ü¡¼¥À¡¼¥³¥ê¡¼¡¢¥´¡¼¥ë¥Ç¥ó¥ì¥È¥ê¥Ð¡¼¡¢¥ª¡¼¥¹¥È¥é¥ê¥¢¥ó¥¥ã¥È¥ë¥É¥Ã¥°¡¢¥µ¥ë¡¼¥¡¢¥Á¥ï¥ï¡¢¥Á¥Ù¥¿¥ó¥Æ¥ê¥¢¡¢¥À¥Ã¥¯¥¹¥Õ¥ó¥É¡¢¥ß¥Ë¥Á¥å¥¢¥·¥å¥Ê¥¦¥¶¡¼ |
500 |
Niemann-Pick disease ¥Ë¡¼¥Þ¥ó¥Ô¥Ã¥¯É |
¿·À¸»ù´ü;ÂÛ»ùÊ¢¿å¡¢´Î磼𡢴ÎÉÔÁ´¤ä¸ÆµÛº¤Æñ¤Ç»àË´¡£ Íĸ¤´ü;¥Ê¥Ã¥¯¥ê¥ó¥°¡¢¥Ð¥é¥ó¥¹ÁÓ¼º¡¢Ãæ¿õ¿À·Ð¾É¾õ¡¢´Î磼ð¡¢áÛÚ» |
¥é¥¤¥½¥¾¡¼¥à¼À´µ¡¢»é¼ÁÂå¼Õ°Û¾ï¾É¡£»ÀÀ¥¹¥Õ¥£¥ó¥´¥ß¥¨¥ê¥Ê¡¼¥¼·ç»¤Ë¤è¤ë°äÅÁÀ¤ÎºÙ˦Æâ»é¼ÁÃßÀÑ¾É | AR | * |
501 |
Niemann-Pick disease, type A ¥Ë¡¼¥Þ¥ó¥Ô¥Ã¥¯ÉÂA·¿ |
´Î磼ð¡¢À®Ä¹ÉÔÁ´¡¢µÞ®¤Ê¿Ê¹ÔÀ¤Î¿À·ÐÊÑÀ¤ÇÁá´ü»àË´ | »ÀÀ¥¹¥Õ¥£¥ó¥´¥ß¥¨¥ê¥Ê¡¼¥¼¤¬Â礤¯·ç»¡£¥Ò¥È¤Ç¤Î³ÎÄê¿ÇÃǤϴÎ磼ð¤òǧ¤á¤¿¾å¤ÇÇò·ìµå¤Ç¤Î¥¹¥Õ¥£¥ó¥´¥ß¥¨¥ê¥Ê¡¼¥¼¤ÎÄêÎ̤«¤é²Äǽ | AR | ¥×¡¼¥É¥ë¡¢Ç¡¢µí¡¢¥¢¥é¥¤¥°¥Þ |
502 |
Niemann-Pick disease, type C ¥Ë¡¼¥Þ¥ó¥Ô¥Ã¥¯ÉÂC·¿ |
ȯ¾ÉǯÎð¤Ï¤Þ¤Á¤Þ¤Á¡£Ã×̿Ū¼À´µ | ºÙ˦¤ÎÃæ¤Ç¥³¥ì¥¹¥Æ¥í¡¼¥ë¤ä¾¤Î»é¼Á¤òŬÀÚ¤ËÂå¼Õ¤µ¤»¤ë¤³¤È¤¬¤Ç¤¤Ê¤¤¤¿¤á ´Î¡¤äç£Â¡¤ÎÃæ¤Ë¥³¥ì¥¹¥Æ¥í¡¼¥ë¤¬²áÅÙ¤ËÃßÀѤµ¤ì¡¢Ç¾¤Ë¤ª¤¤¤Æ¾¤Î»é¼Á¤ÎÎ̤¬²áÅÙ¤ËÁý¤¨¤ë¡£ | AR | * |
513 |
Onychomadesis, symmetrical ÂоÎÀÄÞ¹ÃæÍî¾É |
ÄÞ¤¬Çí¤¬¤ì¤ë¡¢³ä¤ì¤ë¡¢¤È¤ì¤ë | ¹Ã¾õÁ£µ¡Ç½Äã²¼¾É¤ÈÇò·ìµå¹³¸¶¡ÊDLA¡Ë¥¯¥é¥¹¶¤ÈÄÞ¹ÃæÍî¤ÎÀøºßŪ´ØÏ¢À¤Î¸¦µæ¡£¡Ê¹Ã¾õÁ£µ¡Ç½Äã²¼¾É¤ÏDLA°äÅÁ»Ò¤¬Â¾¤Î°ø»Ò¤È¤È¤â¤ËÉ°ø¤Ë´ØÍ¿¤·¤Æ¤¤¤ë²ÄǽÀ¤¬¤¢¤ëÊ£»¨¤Ê¼À´µ¡Ë¡£Çò·ìµå¹³¸¶¤Ï¥Ò¥È¤Î¾ì¹çHuman Leukocyte Antigen¡¢Ä̾ïHLA·¿¤È¸Æ¤Ð¤ì¹ü¿ñ°Ü¿¢¤ÎºÝ¤ËÈó·ì±ï¼Ô´Ö¤ÎŬ¹ç³ÎΨ¤¬¿ôÀé¡Á¿ôËüʬ¤Î°ì¤È¤¤¤ï¤ì¤Æ¤¤¤ë¥¢¥ì¤Ç¡¢¸¤¤â¤½¤Î·¿¤Î¼ïÎà¤Ï¿¤¤ | unknown | E¥»¥Ã¥¿¡¼¡¢G¥»¥Ã¥¿¡¼ |
535 |
Pancreatic insufficiency, exocrine ç¹³°Ê¬ÈçÉÔÁ´ |
ÓÒÅÇ¡¦²¼Î¡¡¦Á餻¡¦Ê¢ÄË¡¦¹¶·âÀ | ÊÌ̾ç¹Â¡°à½Ì¡¦ç¹Â¡Á£Ë¼°à½Ì¡£1¡Á3ºÐ¤Î´Ö¤Ë¸«¤é¤ì¤ä¤¹¤¯¡¢ºÇ½é¤Ï¿©Íߤ¬ÊѤï¤é¤Ê¤¤¤Î¤ËÂνŤ¬¸º¾¯¤¹¤ë¡¢²¼Î¡¤Ï³¥¿§¤Ã¤Ý¤¯Ìý¤Ã¤Ý¤¤½¤¤¤Î»éËÃÊØ¡¢ç¹¾Ã²½¹ÚÁÇʬÈç¤Î¸º¾¯¡£ç¹Â¡¤ÎÁ£Ë¼¤Î³°Ê¬È絡ǽ¤ÎÁÓ¼º¤Ë¤è¤ê¾Ã²½¹ÚÁǤ¬Ê¬È礵¤ì¤Ê¤¯¤Ê¤ë¤³¤È¤ò¸¶°ø¤È¤¹¤ë¾Ã²½µÛ¼ýÉÔÎÉ¡£¾Ã²½ÉÔÎɤˤè¤ë±ÉÍÜÉÔÎɤÇÈéÉæ¤Î´¥Á硦ÉÏÌÓ¡¦Ã¦ÌÓ¡¦ÀÖ·ìµå¸½¾Ý¡¦¶ÚÆù¤Î¸º¾¯¤Ê¤É¤Ë¿Ê¤à | AR | G¥·¥§¥Ñ |
549 |
Persistence of immature pyruvate kinase and hexokinase isozymes *̤½Ï·¿¥Ô¥ë¥Ó¥ó»À¥¥Ê¡¼¥¼µÚ¤Ó¥Ø¥¥½¥¥Ê¡¼¥¼¤Î¥¢¥¤¥½¥¶¥¤¥à»Äα |
* | * | unknown | * |
600 |
Pyruvate dehydrogenase deficiency ¥Ô¥ë¥Ó¥ó»À¥¥Ê¡¼¥¼·ç˳¾É |
»à»º¡¦¿·À¸»Ò»àË´¡£Æý»À¤ÎÃßÀѤˤè¤ë¶ÚÎÏÄã²¼¡¢´Î¾ã³²¡¢¤±¤¤¤ì¤óȯºî¡¢ATP(¥¢¥Ç¥Î¥·¥ó»°¥ê¥ó»À)»ºÀ¸Äã²¼¡¢ÀÖ·ìµåÆâæ¿å¡¢ç£¼ð | PK·ç»¾É¡£±¿Æ°¤ä´¶À÷¾É¤Ç°²½¡¢¥Ò¥È¤Î¾ì¹ç¤Ï´Î¡¤Þ¤¿¤ÏÈéÉæ¤ÎºÙ˦¤Î¹ÚÁdzèÀ¤ò¬Äꤹ¤ë¤³¤È¤Ç¿ÇÃÇ(Ëö¾¿·ìɸËܤÇÍÛùÀÖ·ìµå¤¬¸«¤é¤ì¤ë)¡¢¼£ÎŤÏç£Â¡Å¦½Ð | AR | ¥¯¥é¥ó¥Ð¡¼¡¢¥µ¥»¥Ã¥¯¥¹¥¹¥Ñ¥Ë¥¨¥ë |
601 |
Pyruvate kinase deficiency of erythrocyte ÀÖ·ìµå¥Ô¥ë¥Ó¥ó»À¥¥Ê¡¼¥¼·ç˳¾É |
ÃæÅùÅ٤δÎ磼𡢿ʹÔÀ¹ü¹Å²½¾É¡¢¹ü¿ñÀþ°Ý¾É²«áÕ¡¢°äÅÁÀÍÏ·ìÀÉÏ·ì¤Î¹çÊ» |
Genes:PKLR »à»º¡¦¿·À¸»Ò»àË´¤â¤¢¤ë¤¬5ºÐ°Ê¾å¤Çȯ¾É¤¹¤ë¥±¡¼¥¹¤â¿¤¤¡£ATP»ºÀ¸Äã²¼¤ÇÀÖ·ìµå¤Îæ¿å¤¬µ¯¤ç£¼ð |
AR | ¥Ð¥»¥ó¥¸¡¼¡¢¥Ó¡¼¥°¥ë¡¢¥±¥¢¥ó¡¢¥¦¥¨¥¹¥Æ¥£ |
604 |
Reduced glutathione deficiency, unclassified *̤ʬÎà¤Î´Ô¸µ·¿¥°¥ë¥¿¥Á¥ª¥ó·ç» |
¶Ì¤Í¤®¤ËͶȯ¤µ¤ì¤ëÍÏ·ì |
¶Ì¤Í¤®ÃæÆǤδ¶¼õÀ¡¢·ì±Õ¤Î¹ÚÁǰ۾Ë̳¤Æ»Âç³Ø¤Ç¸¦µæ¤¢¤ê¡£´ðËÜŪ¤Ë̵¾É¾õ¤ÇÌôÉʤäºÙ¶Ý´¶À÷¤ä¤¢¤ë¿©ÉʤÎÀ®Ê¬(¥Ò¥È¤Ç¤Ï¥½¥é¥Þ¥á)¤¬ÍÏ·ì¤òͶ°ú¤¹¤ë¡£´Ô¸µ·¿¥°¥ë¥¿¥Á¥ª¥ó(GSH)¤ÏNADPH(¥Ë¥³¥Á¥ó¥¢¥ß¥É¥¢¥Ç¥Ë¥ó¥¸¥Ì¥¯¥ì¥ª¥Á¥É¥ê¥ó»À)¤È¤È¤â¤ËÀÖ·ìµå¤Î»À²½¤òËɤ°Ìò³ä¤ò¤¹¤ë¹ÚÁÇ ·ì±Õ¤Î¹ÚÁǰ۾´ðËÜŪ¤Ë̵¾É¾õ¤ÇÌôÉʤäºÙ¶Ý´¶À÷¤ä¤¢¤ë¿©ÉʤÎÀ®Ê¬(¥Ò¥È¤Ç¤Ï¥½¥é¥Þ¥á)¤¬ÍÏ·ì¤òͶ°ú¤¹¤ë¡£´Ô¸µ·¿¥°¥ë¥¿¥Á¥ª¥ó(GSH)¤ÏNADPH(¥Ë¥³¥Á¥ó¥¢¥ß¥É¥¢¥Ç¥Ë¥ó¥¸¥Ì¥¯¥ì¥ª¥Á¥É¥ê¥ó»À)¤È¤È¤â¤ËÀÖ·ìµå¤Î»À²½¤òËɤ°Ìò³ä¤ò¤¹¤ë¹ÚÁÇ |
unknown | * |
639 |
Sodium-potassium-ATPase, high activity *¥Ê¥È¥ê¥¦¥à-¥«¥ê¥¦¥à* ¥¢¥Ç¥Î¥·¥ó»°¥ê¥ó»Àʬ²ò¹ÚÁÇ(ATP¥¢¡¼¥¼)*¹â³èÀ(³èÆ°) |
* | * | unknown | * |
678 |
Thyroiditis ¹Ã¾õÁ£±ê |
¹Ã¾õÁ£¤Î¼ðı¡¢ÄË¤ß | ¼«¸ÊÌȱּÀ´µ¤Ê¤É¤Ç¹Ã¾õÁ£¤¬±ê¾É¤òµ¯¤³¤¹(¶¶ËÜÉÂ) | unknown | * |
705 |
Wilson disease ¥¦¥£¥ë¥½¥óÉ |
* |
Genes:ATOX1,COMMD1 Ƽ¤ÎÃßÀѤòÍ褹°äÅÁÀ¼À´µ |
AR | * |
706 |
Wilson disease, COMMD1 type COMMD1·¿¡¡¥¦¥£¥ë¥½¥óÉ |
* | * | unknown | * |